Literature DB >> 22605704

Corynebacterium jeikeium bacteraemia and pulmonary infiltrates in a patient with acute myelogenous leukaemia.

Kota Sato1, Michihiro Uchiyama.   

Abstract

The authors used vancomycin (VCM) to treat Corynebacterium jeikeium bacteraemia and pulmonary infiltrates in a patient with acute myelogenous leukaemia. Pulmonary infiltrates are found in about one-third of patients with haematological pathologies accompanying C jeikeium bacteraemia. Although linezolid and daptomycin are antimicrobial alternatives for treating Corynebacterium infections, the authors believe that VCM is the best choice for immediate treatment success and to prevent pulmonary infiltrates from developing in the presence of bloodstream infection with Corynebacteria in patients with haematological malignancies.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22605704      PMCID： PMC3316829          DOI： 10.1136/bcr.11.2011.5097

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  8 in total

1.  Corynebacterium jeikeium bacteremia in bone marrow transplant patients with Hickman catheters.

Authors:  C C Wang; D Mattson; A Wald
Journal:  Bone Marrow Transplant       Date:  2001-02       Impact factor: 5.483

2.  Biofilm bacteria: formation and comparative susceptibility to antibiotics.

Authors:  Merle E Olson; Howard Ceri; Douglas W Morck; Andre G Buret; Ronald R Read
Journal:  Can J Vet Res       Date:  2002-04       Impact factor: 1.310

Review 3.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters.

Authors:  T J Marrie; J W Costerton
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

5.  In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.

Authors:  José-Luis Gómez-Garcés; Juan-Ignacio Alos; Javier Tamayo
Journal:  Int J Antimicrob Agents       Date:  2007-05-01       Impact factor: 5.283

6.  Intrapulmonary penetration of linezolid.

Authors:  David Honeybourne; Caroline Tobin; Gail Jevons; Jenny Andrews; Richard Wise
Journal:  J Antimicrob Chemother       Date:  2003-05-13       Impact factor: 5.790

Review 7.  Corynebacterium CDC group JK (Corynebacterium jeikeium) sepsis in haematological patients: a report of three cases and a systematic literature review.

Authors:  H van der Lelie; M Leverstein-Van Hall; M Mertens; H C van Zaanen; R H van Oers; B L Thomas; A E von dem Borne; E J Kuijper
Journal:  Scand J Infect Dis       Date:  1995

8.  In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191
  8 in total
  2 in total

1.  Disseminated Corynebacterium jeikeium Infection in Cancer Patients.

Authors:  Shylah M Moore Pardo; Raj H Patel; Asha Ramsakal; John Greene
Journal:  Cureus       Date:  2020-06-22

2.  Unusual source of recurrent Corynebacterium bacteraemia in an immunocompromised patient.

Authors:  Abdul Rahim Ali Bakhsh; Keir Edward Lewis
Journal:  BMJ Case Rep       Date:  2021-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.